The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 678-686

  Yu, Chunping ^a   Zhang, Zhiling ^a   Liao, Wenting ^b   Zhao, Xiaohui ^a   Liu, Liping ^a   Wu, Yanheng ^c   Liu, Zhuowei ^a   Li, Yonghong ^a   Zhong, Yi ^a   Chen, Kun ^d   Li, Jun ^e   Zhou, Fangjian ^a   Song, Libing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR NKX2.8; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

EID: 84863282129     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr321     Document Type: Article

References (33)

1. Kaufman,D.S. et al. (2009) Bladder cancer. Lancet, 374, 239-249.
2. Parekh,D.J. et al. (2006) Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J. Clin. Oncol., 24, 5519-5527.
3. Dimopoulos,M.A. et al. (1998) Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J. Clin. Oncol., 16, 1601-1612.
4. Dinney,C.P. et al. (2004) Focus on bladder cancer. Cancer Cell, 6, 111-116.
5. Apergis,G.A. et al. (1998) A novel nk-2-related transcription factor associated with human fetal liver and hepatocellular carcinoma. J. Biol. Chem., 273, 2917-2925.
6. Tian,J. et al. (2006) Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. Cancer Res., 66, 10399-10407.
7. Harris,T. et al. (2011) Both gene amplification and allelic loss occur at 14q13.3 in lung cancer. Clin. Cancer Res., 17, 690-699.
8. Zhang,Z. et al. (2009) Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 18, 2685-2693.
9. Livak,K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
10. Song,L.B. et al. (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest., 119, 3626-3636.
11. Li,J. et al. (2008) Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin. Cancer Res., 14, 3319-3326.
12. Lin,H. et al. (2010) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One, 5, e15797.
13. Greene FL,P.D. et al. (2002) AJCC Cancer Staging Manual. Lippincott-Raven, Philadelphia, PA.
14. Sauter,G. et al. (2004) World Health Organization Classification of Tumours Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon.
15. Yu,C. et al. (2009) Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis, 30, 894-901.
16. Saussez,S. et al. (2006) Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann. Surg. Oncol., 13, 999-1009.
17. Bao,S. et al. (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell, 5, 329-339.
18. Dijkers,P.F. et al. (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol., 20, 9138-9148.
19. Medema,R.H. et al. (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404, 782-787.
20. Schmidt,M. et al. (2002) Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol., 22, 7842-7852.
21. Nakamura,N. et al. (2000) Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol., 20, 8969-8982.
22. Huang,H. et al. (2005) Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl Acad. Sci. USA, 102, 1649-1654.
23. Cardozo,T. et al. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol., 5, 739-751.
24. Seoane,J. et al. (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell, 117, 211-223.
25. Yang,J.Y. et al. (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol., 10, 138-148.
26. Bienz,M. et al. (2000) Linking colorectal cancer to Wnt signaling. Cell, 103, 311-320.
27. Van der Flier,L.G. et al. (2007) The intestinal Wnt/TCF signature. Gastroenterology, 132, 628-632.
28. Song,L. et al. (2010) Sam68 up-regulation correlates with, and its downregulation inhibits, proliferation and tumourigenicity of breast cancer cells. J. Pathol., 222, 227-237.
29. Li,Z. et al. (2011) Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann. Oncol. doi: 10.1093/annonc/mdr290.
30. Kajiyama,Y. et al. (2002) Regulation of alpha-fetoprotein expression by Nkx2.8. Mol. Cell. Biol., 22, 6122-6130.
31. Kendall,J. et al. (2007) Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc. Natl Acad. Sci. USA, 104, 16663-16668.
32. Hsu,D.S. et al. (2009) Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. Proc. Natl Acad. Sci. USA, 106, 5312-5317.
33. Massague,J. (2004) G1 cell-cycle control and cancer. Nature, 432, 298-306.